Jan Sloves Impressed With Tarık Taştekin’s Raynard’s Phenomenon Demonstration
Jan Sloves, President and Consultant at Vascular Imaging Professionals LLC, reposted Tarık Taştekin’s post on LinkedIn:
“Great demonstration of Raynard’s phenomenon from Tarık Taştekin”
Quoting Tarık Taştekin’s post:
“When the Cold Turns Fingers White
Just a few seconds of cold exposure and the fingertips suddenly lose their color. It may look harmless, even artistic. But what you’re witnessing is a spasm of the small arteries the hallmark of Raynaud’s phenomenon.
In Raynaud’s, cold or emotional stress triggers an exaggerated vasoconstrictive response in digital arterioles, causing a transient reduction in blood flow to the skin.
This leads to a characteristic sequence of color changes:
White (ischemia) – reduced perfusion
Blue (cyanosis) – oxygen deprivation
Red (reactive hyperemia) – reperfusion as vessels dilate again
In this video, as the hand is immersed in warm water, the vessels reopen and oxygenated blood returns a real-time demonstration of microvascular reactivity and the body’s effort to maintain core temperature through peripheral vasospasm.
Raynaud’s phenomenon can be primary (idiopathic) and benign, often seen in young women. However, secondary Raynaud’s may signal underlying systemic disorders such as scleroderma, systemic lupus erythematosus, vasculitis, or thromboangiitis obliterans. Recurrent, painful, or asymmetric attacks should prompt further vascular and rheumatologic evaluation.
What appears to be a simple color change is, in reality, a vivid reflection of vascular physiology in action the body’s fine balance between protection and perfusion.”
Stay updated with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025